Company: IMRX
Filing Date: 2025-09-08
Form Type: 424B3
Source: 0001104659-25-088317
Chunk: 12

Company: Immuneering Corp
Filing Date: 2025-09-08
Form: 424B3
Chunk 12
---
 (or a similar organization or agency succeeding to its functions of reporting prices), the average of the bid prices of any market makers for such security as reported on the Pink Open Market as of such time of determination, or (d) in all other cases, the fair market value of one share of Class A common stock as determined by an independent appraiser selected in good faith by us and reasonably acceptable to the holders of a majority in interest of the Pre-Funded Warrants then outstanding, the fees and expenses of which shall be paid by us.

We do not intend to apply for listing of the Pre-Funded Warrants on any securities exchange or other trading system.

Purchase Warrants

On August 21, 2025, we entered into a securities purchase agreement with certain purchasers named therein, pursuant to which we agreed to sell securities to such purchasers in a private placement. In the private placement, the purchasers received Class A common stock purchase warrants, or the Purchase Warrants, to purchase that number of shares of our Class A common stock equal to 45% of the aggregate number of shares of our Class A common stock and shares underlying our Pre-Funded Warrants stock purchased in the private placement, each with an exercise price equal to $5.50 per share (subject to standard adjustments for stock splits, stock dividend, rights offerings, pro rata distributions and certain anti-dilution adjustment rights). Accordingly, we issued Purchase Warrants to purchase 2,848,096 shares of our Class A common stock upon the closing of the private placement.

As of September 2, 2025, Purchase Warrants to purchase an aggregate of 2,848,096 shares of our common stock were outstanding.

The Purchase Warrants have an exercise price of $5.50 per share and are exercisable on or after August 26, 2025. The Purchase Warrants are exercisable until 5:00 p.m., New York time, on the fifth anniversary of the effective of date of the resale registration statement to be filed by the Company pursuant to the registration rights agreement (as described below). The exercise price and number of shares of common stock issuable upon exercise of the Purchase Warrants may be adjusted in certain circumstances, including in the event of a stock dividend, a forward or reverse split of our shares of common stock, and certain other events. However, the Purchase Warrants will not be adjusted for issuances of common stock at prices below their respective exercise prices.

A holder of a Purchase Warrant may exercise such Purchase